US Stock MarketDetailed Quotes

IGC Pharma (IGC)

Watchlist
  • 0.2960
  • -0.0005-0.17%
Close May 13 16:00 ET
29.24MMarket Cap-4.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

IGC Pharma (IGC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q4)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Total revenue
18.64%350K
-53.64%191K
20.59%328K
-5.50%1.27M
25.98%257K
41.58%412K
-50.99%272K
47.64%1.35M
77.71%295K
-38.55%204K
Operating revenue
167.18%350K
-53.64%191K
20.59%328K
7.62%1.27M
25.98%257K
41.58%412K
-50.99%272K
29.64%1.18M
-21.08%131K
-38.55%204K
Cost of revenue
146.77%306K
-57.01%92K
59.63%174K
6.54%652K
115.49%153K
82.91%214K
-63.67%109K
30.49%612K
20.39%124K
-69.13%71K
Gross profit
-74.27%44K
-50.00%99K
-5.52%154K
-15.55%619K
-21.80%104K
13.79%198K
-36.08%163K
65.84%733K
171.43%171K
30.39%133K
Operating expense
27.51%2.99M
53.12%3M
-19.54%2.06M
-23.42%8.07M
-36.70%1.98M
-26.53%1.96M
6.89%2.56M
-12.34%10.53M
-42.93%2.34M
31.55%3.13M
Selling and administrative expenses
1.14%1.5M
35.45%1.41M
-27.66%1.21M
-34.74%4.41M
-49.28%1.13M
-25.48%1.04M
1.40%1.67M
-20.98%6.76M
-58.83%1.49M
41.55%2.23M
Research and development costs
73.33%1.48M
73.17%1.59M
-4.27%851K
-3.13%3.66M
-5.65%852K
-27.68%917K
19.01%889K
9.01%3.77M
73.43%855K
12.03%903K
Operating profit
-35.53%-2.94M
-64.72%-2.9M
20.49%-1.91M
24.00%-7.45M
37.36%-1.88M
29.35%-1.76M
-12.01%-2.4M
15.32%-9.8M
46.27%-2.17M
-31.61%-3M
Net non-operating interest income expense
Other net income (expense)
409.79%2.22M
2,406.98%1.08M
1,600.00%306K
110.15%325K
101.89%49K
7.50%43K
-71.88%18K
-5,026.15%-3.2M
-8,044.44%-715K
-9,034.48%-2.59M
Special income (charges)
----
----
----
--0
--0
----
----
---3.35M
---722K
---2.62M
-Less:Impairment of capital assets
----
----
----
--0
--0
----
----
--3.35M
--722K
--2.62M
Other non- operating income (expenses)
31,542.86%2.22M
2,406.98%1.08M
1,600.00%306K
127.27%325K
53.13%49K
7.50%43K
-71.88%18K
120.00%143K
-22.22%7K
10.34%32K
Income before tax
74.84%-726K
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
74.84%-726K
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Net income continuous Operations
74.84%-726K
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Minority interest income
Net income attributable to the parent company
74.84%-726K
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.84%-726K
-6.06%-1.82M
32.76%-1.6M
45.22%-7.12M
67.28%-1.83M
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
Basic earnings per share
75.00%-0.01
0.00%-0.02
33.33%-0.02
59.09%-0.09
77.78%-0.02
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
Diluted earnings per share
75.00%-0.01
0.00%-0.02
33.33%-0.02
59.09%-0.09
77.78%-0.02
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
(Q4)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Total revenue 18.64%350K-53.64%191K20.59%328K-5.50%1.27M25.98%257K41.58%412K-50.99%272K47.64%1.35M77.71%295K-38.55%204K
Operating revenue 167.18%350K-53.64%191K20.59%328K7.62%1.27M25.98%257K41.58%412K-50.99%272K29.64%1.18M-21.08%131K-38.55%204K
Cost of revenue 146.77%306K-57.01%92K59.63%174K6.54%652K115.49%153K82.91%214K-63.67%109K30.49%612K20.39%124K-69.13%71K
Gross profit -74.27%44K-50.00%99K-5.52%154K-15.55%619K-21.80%104K13.79%198K-36.08%163K65.84%733K171.43%171K30.39%133K
Operating expense 27.51%2.99M53.12%3M-19.54%2.06M-23.42%8.07M-36.70%1.98M-26.53%1.96M6.89%2.56M-12.34%10.53M-42.93%2.34M31.55%3.13M
Selling and administrative expenses 1.14%1.5M35.45%1.41M-27.66%1.21M-34.74%4.41M-49.28%1.13M-25.48%1.04M1.40%1.67M-20.98%6.76M-58.83%1.49M41.55%2.23M
Research and development costs 73.33%1.48M73.17%1.59M-4.27%851K-3.13%3.66M-5.65%852K-27.68%917K19.01%889K9.01%3.77M73.43%855K12.03%903K
Operating profit -35.53%-2.94M-64.72%-2.9M20.49%-1.91M24.00%-7.45M37.36%-1.88M29.35%-1.76M-12.01%-2.4M15.32%-9.8M46.27%-2.17M-31.61%-3M
Net non-operating interest income expense
Other net income (expense) 409.79%2.22M2,406.98%1.08M1,600.00%306K110.15%325K101.89%49K7.50%43K-71.88%18K-5,026.15%-3.2M-8,044.44%-715K-9,034.48%-2.59M
Special income (charges) --------------0--0-----------3.35M---722K---2.62M
-Less:Impairment of capital assets --------------0--0----------3.35M--722K--2.62M
Other non- operating income (expenses) 31,542.86%2.22M2,406.98%1.08M1,600.00%306K127.27%325K53.13%49K7.50%43K-71.88%18K120.00%143K-22.22%7K10.34%32K
Income before tax 74.84%-726K-6.06%-1.82M32.76%-1.6M45.22%-7.12M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Income tax 0000000000
Net income 74.84%-726K-6.06%-1.82M32.76%-1.6M45.22%-7.12M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Net income continuous Operations 74.84%-726K-6.06%-1.82M32.76%-1.6M45.22%-7.12M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Minority interest income
Net income attributable to the parent company 74.84%-726K-6.06%-1.82M32.76%-1.6M45.22%-7.12M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.84%-726K-6.06%-1.82M32.76%-1.6M45.22%-7.12M67.28%-1.83M29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M
Basic earnings per share 75.00%-0.010.00%-0.0233.33%-0.0259.09%-0.0977.78%-0.0260.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.09
Diluted earnings per share 75.00%-0.010.00%-0.0233.33%-0.0259.09%-0.0977.78%-0.0260.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -